0001562180-16-002661.txt : 20160620
0001562180-16-002661.hdr.sgml : 20160620
20160620160640
ACCESSION NUMBER: 0001562180-16-002661
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160616
FILED AS OF DATE: 20160620
DATE AS OF CHANGE: 20160620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dalal Anupam
CENTRAL INDEX KEY: 0001602474
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 161722204
MAIL ADDRESS:
STREET 1: 88 KEARNY STREET, SUITE 1800
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2016-06-16
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001602474
Dalal Anupam
C/O AKEBIA THERAPEUTICS, INC.
245 FIRST STREET, SUITE 1100
CAMBRIDGE
MA
02142
true
false
false
false
Stock Option (Right to buy)
8.56
2016-06-16
4
A
false
12500.00
0.00
A
2017-06-16
2026-06-16
Common Stock
12500.00
12500.00
D
100% of the option shares vest on the earlier of June 16, 2017 or the date immediately prior to the next annual meeting of the Issuer after
the grant date (the "Vesting Date"), provided that the Reporting Person remains in continuous service as a member of the Issuer's Board of Directors through the applicable Vesting Date, and provided further that the options held by the Reporting Person shall be eligible for vesting acceleration upon a "Change in Control" as defined and provided for in the Issuer's Non-Employee Director Stock Option Award Agreement.
Nicole R. Hadas, attorney-in-fact for Anupam Dalal
2016-06-20